Live attenuated VZV vaccination induces antitumor immunity in ATLL patients

Tuning Rex rules HTLV-1 pathogenesis

Front Immunol. 2022 Sep 16;13:959962. doi: 10.3389/fimmu.2022.959962. eCollection 2022. ABSTRACT HTLV-1 is an oncovirus causing ATL and other inflammatory diseases such as HAM/TSP and HU in about 5% of infected individuals. It is also known that HTLV-1-infected cells...
Generated by Feedzy